Contact and place of performance
ST JOHN, ADELOLA O
Not specified
The objective of this contract is for a Chemical Screening and Optimization Facility (CSOF) with the capability to carry out the production of active recombinant protein, assay development, chemical screening, identification and optimization of chemical lead series and production of milligram to kilogram quantities of materials for in vitro and in vivo testing for contraception and/or reproductive health-related therapeutic indications.
Solicitation 75N94023R00008 seeks to establish a Chemical Screening and Optimization Facility (CSOF) to support research in contraception and reproductive health-related therapeutic indications. The facility will be responsible for the production of active recombinant protein, assay development, and chemical screening. The scope of work includes the identification and optimization of chemical lead series and the production of materials in quantities ranging from milligrams to kilograms for both in vitro and in vivo testing.
The requirement is classified under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC code AN11 for HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH. Adelola O. St John is the designated point of contact for this solicitation. The notice includes two PDF attachments: a solicitation document and a request for proposal document, both posted on April 21, 2023.
This opportunity was originally published on March 31, 2023, and received its most recent update on May 31, 2023. All responses must be submitted by the deadline of June 8, 2023. No specific set-aside designations are identified in the metadata for this acquisition.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.